Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
<h4>Background</h4>Patients with autoimmune arthritis (AA) are at increased risk for impaired cardiac function and heart failure. This may be partly due to the effect of inflammation in heart function. The impact of antirheumatic drugs on cardiac dysfunction in AA remains controversial....
Guardado en:
Autores principales: | Thao H P Nguyen, Morten Wang Fagerland, Gia Deyab, Gunnbjørg Hjeltnes, Ivana Hollan, Mark W Feinberg, Gro Ø Eilertsen, Knut Mikkelsen, Stefan Agewall |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50ab681167014f14972814b1b01a853b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
por: Gia Deyab, et al.
Publicado: (2021) -
Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure
por: Francesca G. Bellagambi, et al.
Publicado: (2021) -
The Effects of Hypertension Stages on N-Terminal-Pro Brain Natriuretic Peptide (NT-Pro-BNP) Level and Left Ventricular Ejection Fraction
por: Kati Sriwiyati, et al.
Publicado: (2019) -
Socioeconomic position is associated with N-terminal pro-brain natriuretic peptide (NT-proBNP)-Results of the population-based Heinz Nixdorf Recall study.
por: Marina Rudman, et al.
Publicado: (2021) -
Association of N-terminal pro-brain natriuretic peptide with mortality in COVID-19: A systematic review and meta-analysis
por: Dhanya Nair, et al.
Publicado: (2021)